USD 10.21
(-2.3%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -186.63 Million USD | -22.67% |
2022 | -152.14 Million USD | -5.42% |
2021 | -144.32 Million USD | -82.71% |
2020 | -78.99 Million USD | -38.82% |
2019 | -56.9 Million USD | -96.38% |
2018 | -28.97 Million USD | -1163.08% |
2017 | -2.29 Million USD | 92.43% |
2016 | -30.31 Million USD | 83.03% |
2015 | -178.67 Million USD | -1287.02% |
2014 | -12.88 Million USD | 84.33% |
2013 | -82.22 Million USD | -431.9% |
2012 | -15.45 Million USD | 30.31% |
2011 | -22.18 Million USD | -54.52% |
2010 | -14.35 Million USD | -8.02% |
2009 | -13.28 Million USD | 54.63% |
2008 | -29.28 Million USD | -44.98% |
2007 | -20.2 Million USD | 21.75% |
2006 | -25.81 Million USD | -83.69% |
2005 | -14.05 Million USD | -2858.67% |
2004 | 509.45 Thousand USD | 161.12% |
2003 | -833.5 Thousand USD | 20.01% |
2002 | -1.04 Million USD | -1234.05% |
2001 | 91.88 Thousand USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -48.49 Million USD | 1.19% |
2024 Q3 | -39.61 Million USD | 2.62% |
2024 Q2 | -40.68 Million USD | 16.12% |
2023 FY | -186.63 Million USD | -22.67% |
2023 Q2 | -51.37 Million USD | -18.03% |
2023 Q3 | -42.65 Million USD | 16.98% |
2023 Q4 | -49.07 Million USD | -15.06% |
2023 Q1 | -43.52 Million USD | -24.42% |
2022 Q2 | -37.32 Million USD | 12.89% |
2022 Q4 | -34.98 Million USD | 5.44% |
2022 FY | -152.14 Million USD | -5.42% |
2022 Q1 | -42.84 Million USD | -6.61% |
2022 Q3 | -36.99 Million USD | 0.86% |
2021 Q2 | -38.2 Million USD | -66.81% |
2021 Q4 | -40.18 Million USD | 6.61% |
2021 FY | -144.32 Million USD | -82.71% |
2021 Q1 | -22.9 Million USD | 14.53% |
2021 Q3 | -43.03 Million USD | -12.63% |
2020 Q2 | -15.8 Million USD | 23.73% |
2020 Q3 | -15.66 Million USD | 0.86% |
2020 FY | -78.99 Million USD | -38.82% |
2020 Q4 | -26.79 Million USD | -71.03% |
2020 Q1 | -20.72 Million USD | -21.67% |
2019 Q3 | -14.56 Million USD | -17.14% |
2019 Q2 | -12.43 Million USD | 4.1% |
2019 Q1 | -12.96 Million USD | -22.02% |
2019 FY | -56.9 Million USD | -96.38% |
2019 Q4 | -17.03 Million USD | -16.91% |
2018 Q3 | -9.35 Million USD | -32.21% |
2018 Q4 | -10.62 Million USD | -13.61% |
2018 FY | -28.97 Million USD | -1163.08% |
2018 Q1 | -1.91 Million USD | -121.16% |
2018 Q2 | -7.07 Million USD | -269.31% |
2017 Q4 | 9.05 Million USD | 388.65% |
2017 FY | -2.29 Million USD | 92.43% |
2017 Q3 | -3.13 Million USD | -16.31% |
2017 Q2 | -2.69 Million USD | 51.1% |
2017 Q1 | -5.51 Million USD | -16.2% |
2016 FY | -30.31 Million USD | 83.03% |
2016 Q1 | -6.61 Million USD | 33.18% |
2016 Q4 | -4.74 Million USD | 65.41% |
2016 Q3 | -13.72 Million USD | -162.2% |
2016 Q2 | -5.23 Million USD | 20.92% |
2015 Q1 | -4.56 Million USD | -1570.7% |
2015 Q4 | -9.9 Million USD | 93.82% |
2015 FY | -178.67 Million USD | -1287.02% |
2015 Q2 | -3.94 Million USD | 13.46% |
2015 Q3 | -160.26 Million USD | -3960.43% |
2014 Q3 | -3.04 Million USD | -5.04% |
2014 FY | -12.88 Million USD | 84.33% |
2014 Q4 | -273 Thousand USD | 91.02% |
2014 Q1 | -6.67 Million USD | 88.95% |
2014 Q2 | -2.89 Million USD | 56.62% |
2013 Q4 | -60.4 Million USD | -316.31% |
2013 FY | -82.22 Million USD | -431.9% |
2013 Q3 | -14.51 Million USD | -211.31% |
2013 Q1 | -2.64 Million USD | 50.53% |
2013 Q2 | -4.66 Million USD | -75.95% |
2012 Q4 | -5.35 Million USD | -116.89% |
2012 Q1 | -1.26 Million USD | 92.1% |
2012 Q3 | -2.46 Million USD | 61.26% |
2012 FY | -15.45 Million USD | 30.31% |
2012 Q2 | -6.37 Million USD | -405.47% |
2011 Q3 | -1.3 Million USD | 57.16% |
2011 FY | -22.18 Million USD | -54.52% |
2011 Q4 | -15.96 Million USD | -1124.39% |
2011 Q2 | -3.04 Million USD | -63.04% |
2011 Q1 | -1.86 Million USD | 35.08% |
2010 Q1 | -4.71 Million USD | -256.82% |
2010 FY | -14.35 Million USD | -8.02% |
2010 Q2 | -2.97 Million USD | 36.75% |
2010 Q4 | -2.87 Million USD | 24.12% |
2010 Q3 | -3.79 Million USD | -27.22% |
2009 Q4 | -1.32 Million USD | -2.88% |
2009 Q2 | -6.3 Million USD | -43.81% |
2009 Q1 | -4.38 Million USD | 13.35% |
2009 FY | -13.28 Million USD | 54.63% |
2009 Q3 | -1.28 Million USD | 79.64% |
2008 Q2 | -3.59 Million USD | 77.24% |
2008 FY | -29.28 Million USD | -44.98% |
2008 Q4 | -5.05 Million USD | -4.07% |
2008 Q1 | -15.77 Million USD | -40.3% |
2008 Q3 | -4.86 Million USD | -35.34% |
2007 FY | -20.2 Million USD | 21.75% |
2007 Q2 | -703 Thousand USD | 73.71% |
2007 Q3 | -5.57 Million USD | -693.46% |
2007 Q4 | -11.24 Million USD | -101.63% |
2007 Q1 | -2.67 Million USD | 76.39% |
2006 FY | -25.81 Million USD | -83.69% |
2006 Q4 | -11.32 Million USD | -108.24% |
2006 Q1 | -5.87 Million USD | -88.15% |
2006 Q2 | -3.17 Million USD | 45.92% |
2006 Q3 | -5.43 Million USD | -71.11% |
2005 Q2 | -3.12 Million USD | 33.32% |
2005 Q4 | -3.12 Million USD | 0.0% |
2005 Q1 | -4.68 Million USD | -3777.86% |
2005 Q3 | -3.12 Million USD | 0.0% |
2005 FY | -14.05 Million USD | -2858.67% |
2004 Q3 | 127.36 Thousand USD | 0.0% |
2004 Q1 | 127.36 Thousand USD | 0.0% |
2004 Q2 | 127.36 Thousand USD | 0.0% |
2004 Q4 | 127.36 Thousand USD | -0.0% |
2004 FY | 509.45 Thousand USD | 161.12% |
2003 FY | -833.5 Thousand USD | 20.01% |
2002 FY | -1.04 Million USD | -1234.05% |
2001 FY | 91.88 Thousand USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Acutus Medical, Inc. | -81.66 Million USD | -128.547% |
Cerus Corporation | -37.48 Million USD | -397.847% |
OrthoPediatrics Corp. | -20.97 Million USD | -789.854% |
PetVivo Holdings, Inc. | -10.95 Million USD | -1603.633% |
Talis Biomedical Corporation | -62 Million USD | -200.995% |
Vivos Therapeutics, Inc. | -13.58 Million USD | -1274.056% |
Inogen, Inc. | -102.44 Million USD | -82.176% |
Spectral AI, Inc. | -20.85 Million USD | -794.975% |
Nano-X Imaging Ltd. | -60.77 Million USD | -207.092% |
CVRx, Inc. | -41.19 Million USD | -353.016% |
DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 29253.259% |
Helius Medical Technologies, Inc. | -8.85 Million USD | -2008.904% |
Orthofix Medical Inc. | -151.39 Million USD | -23.279% |
Venus Concept Inc. | -37.25 Million USD | -401.042% |
Accelerate Diagnostics, Inc. | -61.61 Million USD | -202.895% |
Bioventus Inc. | -156.23 Million USD | -19.464% |
BrainsWay Ltd. | -4.19 Million USD | -4346.938% |
Envoy Medical, Inc. | -29.9 Million USD | -524.04% |
electroCore, Inc. | -18.83 Million USD | -890.963% |
IceCure Medical Ltd | -14.65 Million USD | -1173.806% |
Lucid Diagnostics Inc. | -52.66 Million USD | -254.38% |
Monogram Orthopaedics, Inc. | -13.74 Million USD | -1257.84% |
MaxCyte, Inc. | -37.92 Million USD | -392.15% |
NeuroOne Medical Technologies Corporation | -11.85 Million USD | -1473.744% |
Nexalin Technology, Inc. | -4.64 Million USD | -3914.835% |
PAVmed Inc | -64.17 Million USD | -190.827% |
Rapid Micro Biosystems, Inc. | -52.46 Million USD | -255.725% |
RxSight, Inc. | -48.6 Million USD | -283.966% |
Sight Sciences, Inc. | -55.54 Million USD | -236.0% |
SI-BONE, Inc. | -43.33 Million USD | -330.677% |
TELA Bio, Inc. | -46.66 Million USD | -299.961% |
TriSalus Life Sciences, Inc. | -59.03 Million USD | -216.132% |
Treace Medical Concepts, Inc. | -49.52 Million USD | -276.841% |
LivaNova PLC | 17.54 Million USD | 1163.707% |
908 Devices Inc. | -36.39 Million USD | -412.756% |
Nemaura Medical Inc. | -14.14 Million USD | -1219.581% |
NeuroPace, Inc. | -32.95 Million USD | -466.325% |
LENSAR, Inc. | -14.38 Million USD | -1197.629% |
Apyx Medical Corporation | -18.71 Million USD | -897.371% |
Cutera, Inc. | -162.83 Million USD | -14.619% |
STRATA Skin Sciences, Inc. | -10.83 Million USD | -1623.343% |
BioSig Technologies, Inc. | -29.04 Million USD | -542.671% |
Anika Therapeutics, Inc. | -82.66 Million USD | -125.771% |
ClearPoint Neuro, Inc. | -22.08 Million USD | -744.936% |
Integra LifeSciences Holdings Corporation | 67.74 Million USD | 375.517% |
Axonics, Inc. | -6.08 Million USD | -2965.67% |
Outset Medical, Inc. | -172.79 Million USD | -8.01% |
IRIDEX Corporation | -9.57 Million USD | -1850.24% |
PROCEPT BioRobotics Corporation | -105.89 Million USD | -76.245% |
IRadimed Corporation | 17.19 Million USD | 1185.561% |
Tivic Health Systems, Inc. | -8.24 Million USD | -2163.925% |
INVO Bioscience, Inc. | -8.03 Million USD | -2222.925% |
Telesis Bio, Inc. | -47.72 Million USD | -291.078% |
Viemed Healthcare, Inc. | 10.24 Million USD | 1922.103% |
Varex Imaging Corporation | -47.7 Million USD | -291.275% |
Quipt Home Medical Corp. | -2.78 Million USD | -6603.951% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1553.713% |
Pulmonx Corporation | -60.84 Million USD | -206.753% |
Dynatronics Corporation | -2.69 Million USD | -6818.363% |
Modular Medical, Inc. | -17.47 Million USD | -968.334% |
ReShape Lifesciences Inc. | -11.38 Million USD | -1539.045% |
Semler Scientific, Inc. | 20.58 Million USD | 1006.758% |
InMode Ltd. | 197.91 Million USD | 194.3% |
Bruker Corporation | 427.2 Million USD | 143.689% |
Cytosorbents Corporation | -28.5 Million USD | -554.7% |
DexCom, Inc. | 541.5 Million USD | 134.467% |
Align Technology, Inc. | 445.05 Million USD | 141.936% |
Viveve Medical, Inc. | -22.02 Million USD | -747.315% |
ZimVie Inc. | -393.28 Million USD | 52.543% |
Movano Inc. | -29.28 Million USD | -537.36% |
Cytek Biosciences, Inc. | -12.14 Million USD | -1436.368% |
Nexalin Technology, Inc. | -4.64 Million USD | -3914.835% |
DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 29253.259% |
Tandem Diabetes Care, Inc. | -222.61 Million USD | 16.16% |
Profound Medical Corp. | -28.56 Million USD | -553.289% |
Insulet Corporation | 206.3 Million USD | 190.469% |
enVVeno Medical Corporation | -23.51 Million USD | -693.664% |
Surmodics, Inc. | -11.54 Million USD | -1517.033% |
iCAD, Inc. | -4.84 Million USD | -3750.588% |
Nuwellis, Inc. | -20.2 Million USD | -823.539% |
Biotricity, Inc. | -14.09 Million USD | -1224.211% |
iRhythm Technologies, Inc. | -123.4 Million USD | -51.239% |
Aethlon Medical, Inc. | -12.2 Million USD | -1428.795% |
InspireMD, Inc. | -19.91 Million USD | -837.126% |
PAVmed Inc. | -64.17 Million USD | -190.827% |
BIOLASE, Inc. | -20.63 Million USD | -804.604% |
Beyond Air, Inc. | -60.24 Million USD | -209.814% |
FONAR Corporation | 10.56 Million USD | 1866.168% |
AxoGen, Inc. | -21.71 Million USD | -759.449% |
Vivani Medical, Inc. | -25.65 Million USD | -627.577% |
Tactile Systems Technology, Inc. | 28.51 Million USD | 754.526% |
Inari Medical, Inc. | -1.63 Million USD | -11308.191% |
UFP Technologies, Inc. | 44.92 Million USD | 515.453% |
QT Imaging Holdings, Inc. | -5.13 Million USD | -3536.515% |
Heart Test Laboratories, Inc. | -6.6 Million USD | -2725.619% |
Tenon Medical, Inc. | -15.58 Million USD | -1097.856% |
Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -1109.892% |
Co-Diagnostics, Inc. | -35.33 Million USD | -428.228% |
AdaptHealth Corp. | -678.89 Million USD | 72.509% |
Sintx Technologies, Inc. | -8.25 Million USD | -2159.814% |
NanoVibronix, Inc. | -3.71 Million USD | -4929.318% |
Quanterix Corporation | -32.33 Million USD | -477.219% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1553.713% |
Sensus Healthcare, Inc. | 485 Thousand USD | 38582.062% |
Pacific Biosciences of California, Inc. | -306.73 Million USD | 39.153% |
TransMedics Group, Inc. | -25.02 Million USD | -645.717% |
ReWalk Robotics Ltd. | -22.13 Million USD | -743.257% |
NeuroMetrix, Inc. | -6.52 Million USD | -2758.387% |
Hyperfine, Inc. | -44.23 Million USD | -321.895% |
Establishment Labs Holdings Inc. | -78.5 Million USD | -137.749% |
Biomerica, Inc. | -5.97 Million USD | -3022.081% |
Bone Biologics Corporation | -8.94 Million USD | -1985.636% |
AVITA Medical, Inc. | -39.16 Million USD | -376.504% |
Bluejay Diagnostics, Inc. | -9.95 Million USD | -1775.026% |
Silk Road Medical, Inc | -55.74 Million USD | -234.819% |